Lundbeck Loses U.K. Patent Case Over Cipralex

Law360, New York (May 7, 2007, 12:00 AM EDT) -- Danish pharmaceutical company H. Lundbeck A/S suffered a blow Friday when a British court ruled against it in a dispute with three generic makers over a patent for its top-selling antidepressant drug, Cipralex.

The three generic companies, Teva Pharmaceuticals Ltd., Generics (UK) Ltd. and Arrow Generics Ltd., filed separate complaints alleging that certain claims in Lundbeck’s Cipralex patent were invalid because they were obvious, not novel because of prior art and insufficient. The United Kingdom’s High Court of Justice’s Patent Court combined the three claims into...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.